SIRT3 and hepatocellular carcinoma: These findings proved that SIRT3 activation reduced cDDP-induced acetylation of COX-2, which in turn, suppressed mito-COX-2/ p-Drp1Ser616 interaction, and subsequently sensitized HCC cells to the mitochondria-dependent apoptosis.